218 related articles for article (PubMed ID: 35855933)
1. Latest developments in the pathobiology of Ewing sarcoma.
Karlina I; Schroeder BA; Kirgizov K; Romantsova O; Istranov AL; Nedorubov A; Timashev P; Ulasov I
J Bone Oncol; 2022 Aug; 35():100440. PubMed ID: 35855933
[TBL] [Abstract][Full Text] [Related]
2. RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.
Arora S; Gonzales IM; Hagelstrom RT; Beaudry C; Choudhary A; Sima C; Tibes R; Mousses S; Azorsa DO
Mol Cancer; 2010 Aug; 9():218. PubMed ID: 20718987
[TBL] [Abstract][Full Text] [Related]
3. Potential approaches to the treatment of Ewing's sarcoma.
Yu H; Ge Y; Guo L; Huang L
Oncotarget; 2017 Jan; 8(3):5523-5539. PubMed ID: 27740934
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapies in Ewing's sarcoma.
Scotlandi K
Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
[TBL] [Abstract][Full Text] [Related]
6. Comparative characteristics of small cell lung cancer and Ewing's sarcoma: a narrative review.
Hamilton G
Transl Lung Cancer Res; 2022 Jun; 11(6):1185-1198. PubMed ID: 35832443
[TBL] [Abstract][Full Text] [Related]
7. Current Status of Proteomics in Ewing's Sarcoma.
Kondo T
Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
[TBL] [Abstract][Full Text] [Related]
8. Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A.
Fu J; Jiang H; Wu C; Jiang Y; Xiao L; Tian Y
Mol Med Rep; 2016 Jul; 14(1):995-1001. PubMed ID: 27222229
[TBL] [Abstract][Full Text] [Related]
9. miR-185 suppresses progression of Ewing's sarcoma via inhibiting the PI3K/AKT and Wnt/β-catenin pathways.
Zhang S; Li D; Jiao GJ; Wang HL; Yan TB
Onco Targets Ther; 2018; 11():7967-7977. PubMed ID: 30519038
[TBL] [Abstract][Full Text] [Related]
10. Current treatment for Ewing's sarcoma.
Thacker MM; Temple HT; Scully SP
Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
[TBL] [Abstract][Full Text] [Related]
11. A child with Ewing's sarcoma in scapula: A rare case report.
Shashaa MN; Hamza A; AlHashemi M; Alyousfi R; Deebo MAA; Katnaji J
Int J Surg Case Rep; 2021 Aug; 85():106182. PubMed ID: 34247121
[TBL] [Abstract][Full Text] [Related]
12. An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.
Winter GE; Rix U; Lissat A; Stukalov A; Müllner MK; Bennett KL; Colinge J; Nijman SM; Kubicek S; Kovar H; Kontny U; Superti-Furga G
Mol Cancer Ther; 2011 Oct; 10(10):1846-56. PubMed ID: 21768330
[TBL] [Abstract][Full Text] [Related]
13. The Landscape of Regulatory Noncoding RNAs in Ewing's Sarcoma.
Barrett C; Budhiraja A; Parashar V; Batish M
Biomedicines; 2021 Jul; 9(8):. PubMed ID: 34440137
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.
Zhang S; Guo W; Ren TT; Lu XC; Tang GQ; Zhao FL
Anticancer Drugs; 2012 Jan; 23(1):108-18. PubMed ID: 21946058
[TBL] [Abstract][Full Text] [Related]
15. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
16. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous metastases from Ewing's sarcoma: report of two cases.
Izquierdo MJ; Pastor MA; Carrasco L; Requena C; Fariña MC; Martín L; Sarasa JL; Requena L
Clin Exp Dermatol; 2002 Mar; 27(2):123-8. PubMed ID: 11952704
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
19. The potential for molecular therapeutic targets in Ewing's sarcoma.
McAllister NR; Lessnick SL
Curr Treat Options Oncol; 2005 Nov; 6(6):461-71. PubMed ID: 16242051
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetically confirmed primary Ewing's sarcoma of the pancreas.
Golhar A; Ray S; Haugk B; Singhvi SK
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28473430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
